Inflammatory Response to CSII Catheters in a Tummy Tuck Model

Plain-language summary

This study examines the body's inflammatory response to continuous subcutaneous insulin infusion catheters in people scheduled for an elective tummy tuck (abdominoplasty). It was designed for men and women aged 18 and over scheduled for elective abdominoplasty. The study was conducted as a trial without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

Medical University of Graz

Intervention

Continous Subcutaneous Insulin Infusion Catheter

Start date

2/1/2018

Estimated completion

12/31/2024

Countries

Austria

Related genes

Locations

• Graz, Austria

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Men and women, age 18 years or older
* Scheduled elective abdominoplasty at the Dpt. of Plastic Surgery, Medical University of Graz
* Signed informed consent form

Exclusion Criteria:

* Allergy to Teflon or steel
* Known skin diseases (atopic dermatitis, psoriasis)
* History of immunodeficiency diseases
* Patients on glucocorticoid or other immunomodulating therapy
* History of bleeding disorder
* Pregnancy or planned pregnancy
* Unable to fully understand study procedures and to provide informed consent